KRAS and non-small cell lung carcinoma: In our current study, we evaluated the cytotoxic impact of P-AscH− on NSCLC cell lines harboring distinct KRAS genetic background; H292 with wild-type KRAS; H23 with KRASG12C; and H460 with KRASQ61H (Supplementary Table S2).